톨-유사 수용체 7 (TLR7) 효능제로서의 1H-피라졸로[4,3-d]피리미딘 화합물

화학식 I에 따른 화합물은 톨-유사 수용체 7 (TLR7)의 효능제로서 유용하다. 이러한 화합물은 암 치료, 특히 항암 면역요법제와 조합하여 또는 백신 보조제로서 사용될 수 있다. JPEGpct00189.jpg2558 Compounds according to formula I are useful as agonists of Toll-like receptor 7 (TLR7). Such compounds can be used in cancer treatment, especially in combination with an anti-can...

Full description

Saved in:
Bibliographic Details
Main Authors CHENG HENG, GANGWAR SANJEEV, POUDEL YAM B, GILL PATRICE, GAVAI ASHVINIKUMAR V, SIVAPRAKASAM PRASANNA, DONNELL ANDREW F, JOHNSON WALTER L, ANDAPPAN MURUGAIAH SUBBAIAH MURUGAIAH, TARBY CHRISTINE M
Format Patent
LanguageKorean
Published 30.09.2022
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:화학식 I에 따른 화합물은 톨-유사 수용체 7 (TLR7)의 효능제로서 유용하다. 이러한 화합물은 암 치료, 특히 항암 면역요법제와 조합하여 또는 백신 보조제로서 사용될 수 있다. JPEGpct00189.jpg2558 Compounds according to formula I are useful as agonists of Toll-like receptor 7 (TLR7). Such compounds can be used in cancer treatment, especially in combination with an anti-cancer immunotherapy agent, or as a vaccine adjuvant.
Bibliography:Application Number: KR20227029267